These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain. Owens MJ, Bissette G, Nemeroff CB. Synapse; 1989; 4(3):196-202. PubMed ID: 2575286 [Abstract] [Full Text] [Related]
8. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder. Amsterdam JD, Kaplan M, Potter L, Bloom L, Rickels K. Psychopharmacology (Berl); 1986; 88(4):484-8. PubMed ID: 3085137 [Abstract] [Full Text] [Related]
9. Mechanism of triazolo-benzodiazepine and benzodiazepine action in anxiety and depression: behavioral studies with concomitant in vivo CA1 hippocampal norepinephrine and serotonin release detection in the behaving animal. Broderick PA, Hope O, Jeannot P. Prog Neuropsychopharmacol Biol Psychiatry; 1998 Feb; 22(2):353-86. PubMed ID: 9608607 [Abstract] [Full Text] [Related]
10. The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard. File SE, Pellow S. Br J Pharmacol; 1985 Nov; 86(3):729-35. PubMed ID: 2866006 [Abstract] [Full Text] [Related]
16. Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate after single oral doses of each compound in healthy volunteers. Fleishaker JC, Friedman H, Pollock SR, Smith TC. Clin Pharmacol Ther; 1990 Dec; 48(6):652-64. PubMed ID: 2249377 [Abstract] [Full Text] [Related]
17. The effect of antidepressants on L-5HTP-induced changes in rat plasma corticosteroids. Lahti RA, Barsuhn C. Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):343-9. PubMed ID: 6967219 [Abstract] [Full Text] [Related]
19. Triazolobenzodiazepines antagonize the effects of anxiogenic drugs mediated at three different central nervous system sites. File SE, Pellow S. Neurosci Lett; 1985 Oct 24; 61(1-2):115-9. PubMed ID: 2867497 [Abstract] [Full Text] [Related]
20. Comparison of adinazolam, amitriptyline, and diazepam in endogenous depressive inpatients exhibiting DST nonsuppression or abnormal contingent negative variation. Ansseau M, Devoitille JM, Papart P, Vanbrabant E, Mantanus H, Timsit-Berthier M. J Clin Psychopharmacol; 1991 Jun 24; 11(3):160-5. PubMed ID: 2066454 [Abstract] [Full Text] [Related] Page: [Next] [New Search]